20 June 2022 : Clinical Research
A Single-Center Retrospective Study to Compare the Efficacy and Safety of Modified FOLFIRINOX with S-1 as Adjuvant Chemotherapy in 71 Patients with Resected Pancreatic Carcinoma
Linhua Yao1ABCEF, Chengwu Tang2ABCEF, Wenming Feng2ABFG, Hanbin Dai2ABCE*DOI: 10.12659/MSM.937136
Med Sci Monit 2022; 28:e937136
Table 3 Sites of first relapse.
| Site | S-1 group | mFFX group |
|---|---|---|
| Local | 9 | 8 |
| Liver | 6 | 5 |
| Abdominal lymph node | 5 | 5 |
| Peritoneum | 3 | 3 |
| Lung | 2 | 1 |
| Others | 1 | 1 |